Founded in Chicago, Illinois, in 2017, Cardio Diagnostics Holdings, Inc. specializes in the creation and market introduction of clinical tests. These diagnostic tools leverage epigenetics to assess cardiovascular disease risk. Among its offerings is Epi+Gen CHD, a test designed to predict the risk of symptomatic coronary heart disease over a three-year timeframe.
The current price of CDIOW is $0.01 USD — it has increased by +15.7% in the past 24 hours. Watch Cardio Diagnostics stock price performance more closely on the chart.
What is Cardio Diagnostics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Cardio Diagnostics stocks are traded under the ticker CDIOW.
Is Cardio Diagnostics stock price growing?▼
CDIOW stock has risen by +16.67% compared to the previous week, the month change is a -7.28% fall, over the last year Cardio Diagnostics has showed a -3.45% decrease.
What is Cardio Diagnostics market cap?▼
Today Cardio Diagnostics has the market capitalization of 41,432.57
When is the next Cardio Diagnostics earnings date?▼
Cardio Diagnostics is going to release the next earnings report on September 02, 2026.
What is Cardio Diagnostics revenue for the last year?▼
Cardio Diagnostics revenue for the last year amounts to 15,000 USD.
What is Cardio Diagnostics net income for the last year?▼
CDIOW net income for the last year is -6.5M USD.
How many employees does Cardio Diagnostics have?▼
As of July 30, 2026, the company has 15 employees.
In which sector is Cardio Diagnostics located?▼
Cardio Diagnostics operates in the Health & Wellness sector.
When did Cardio Diagnostics complete a stock split?▼
The last stock split for Cardio Diagnostics was on May 13, 2025 with a ratio of 1:30.
Where is Cardio Diagnostics headquartered?▼
Cardio Diagnostics is headquartered in Chicago, United States.